20 June 2022
How to make the most of AI in biopharma research–Nature Feature
Rapidly accelerating data generation has outgrown the rate at which human beings can digest in a meaningful way… artificial intelligence will become a necessity, not just a novelty, for biotech.
Erwin Seinin, eLabNext founder and managing director
In this ad feature with Springer Nature Group [Nature Magazine], we share how to make the most of artificial intelligence (AI) in biopharma research–especially in creating an optimized and interconnected workflow when working with an ELN platform.
This article features:
- Taylor Chartier from Modicus Prime
- Vadim Nazarov from ImmunoMind.
- Plus: Erwin Seinen and Zareh Zurabyan from eLabNext
Featured News
The digital lab: in search of leaner, greener operations–Nature Feature
Laboratories consume between give and ten times more energy than commercial office spaces per square foot, and about four times more water. Rachael Relph, chief
Learn more
Lab Automation, AI & Digital Transformation–New SelectScience article feature
Laboratory research in the past decade has moved vastly into paperless processes. New technologies and tools are entering the market every day to aid and
Learn more
Integrating AI with digital lab tools–SelectScience Article
Artificial intelligence (AI) tools may be the next step needed to revolutionize life science research; however, many R&D companies are not internally equipped to build
Learn more
Get started with eLabNext today
Personal demo, free lab workflow assessment, and friendly expert guidance.
